FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283720170> ?p ?o ?g. }

• W4283720170 endingPage "784" @default.
• W4283720170 startingPage "779" @default.
• W4283720170 abstract "Objective: To investigate the relationship between psoriasis severity and clinical features in psoriatic arthritis (PsA). Methods: Patients were recruited from the Chinese REgistry of Psoriatic ARthritis (CREPAR) between December 2018 and June 2021, and data were collected including the baseline demographic characteristics, various clinical manifestations (including arthritis, nail disease, comorbidities), laboratory tests[including erythrocyte sedimentation rate(ESR), C-reactive protein (CRP)], health assessment questionnaire (HAQ). Body surface area (BSA) and psoriasis area and severity index (PASI) were selected for the tools of assessment of cutaneous psoriasis. Patients were divided to two groups, including the severe psoriasis group (BSA>10%) and the non-severe psoriasis group (BSA≤10%). Disease assessment included ankylosing spondylitis disease activity score (ASDAS), disease activity score 28 (DAS28) and disease activity in psoriatic arthritis (DAPSA). Results: 1 074 eligible patients with PsA were recruited, and 106 (9.9%) had severe psoriasis. Compared with non-severe psoriasis group, the severe psoriasis group had more peripheral joint involvement (including patients with ever or current peripheral arthritis, 94.3% vs. 85.6%), more polyarticular joint involvement (including patients with current peripheral arthritis, 74.0% vs. 58.2%), more axial joint involvement (51.4% vs. 39.9%), more nail disease (72.6% vs. 61.4%), more frequency of smoking (20.2% vs. 18.7%), and higher proportion of hypertension (23.4% vs. 14.4%). In addition, the severe psoriasis group had higher level of ESR [33(10, 70) mm/1h vs. 20(9, 38) mm/1h] and CRP [18.6(5.0, 60.8) mg/L vs. 7.0(2.4, 18.1) mg/L], higher values of DAS28-ESR (4.5±1.7 vs. 3.7±1.5), DAS28-CRP (4.2±1.5 vs. 3.4±1.4), ASDAS-ESR (3.5±1.4 vs. 2.6±1.2), and ASDAS-CRP(3.4±1.6 vs. 2.5±1.2), higher scores of HAQ [0.6(0.1, 1.0) vs. 0.3(0.0, 0.8)]. Conclusion: Patients with PsA with severe psoriasis bore a heavier disease burden. Therefore, clinicians were supposed to pay more attention to them. In addition to skin lesions, they should also focus on examination of other clinical manifestations, such as joints and nails.目的： 探讨银屑病关节炎（PsA）患者皮疹严重程度与临床特征的关系。 方法： 从中国PsA注册研究系统（CREPAR）中选2018年12月至2021年6月注册的PsA患者，收集其基线的人口学资料、临床表现（包括关节受累、指甲改变、合并症等）、实验室检查［红细胞沉降率（ESR）、C反应蛋白（CRP）等］、健康评估问卷评分、银屑病皮疹体表受累面积（BSA）、银屑病皮肤损害面积及严重程度指数（PASI），BSA>10%为重度皮疹者；BSA≤10%为非重度皮疹者。应用强直性脊柱炎病情活动度评分（ASDAS）、28个关节活动度评分（DAS28）、PsA疾病活动指数（DAPSA）等评估疾病活动情况。记录基于ESR计算的DAS28（DAS28-ESR）和ASDAS（ASDAS-ESR）。记录基于CRP水平计算的DAS28（DAS28-CRP）和ASDAS（ASDAS-CRP）。 结果： 纳入1 074例PsA患者，其中106例（9.9%）患者BSA>10%。与BSA≤10%者比，BSA>10%者外周关节受累（含既往或目前受累）比例高（94.3%比85.6%），多关节受累（指目前有外周关节受累者）比例高（74.0%比58.2%），中轴关节受累比例高（51.4%比39.9%），指甲改变比例高（72.6%比61.4%）；吸烟比例高（20.2%比18.7%），高血压比例高（23.4%比14.4%），冠心病比例高（3.8%比1.2%）；ESR水平高［33（10，70）mm/1h 比 20（9，38）mm/1h］，CRP水平高［18.6（5.0，60.8）mg/L比7.0（2.4，18.1）mg/L］；DAS28-ESR（4.5±1.7比3.7±1.5）、DAS28-CRP（4.2±1.5比3.4±1.4）、ASDAS-ESR（3.5±1.4比2.6±1.2）、ASDAS-CRP（3.4±1.6比2.5±1.2）高，健康评估问卷评分高［0.6（0.1，1.0）分比 0.3（0.0，0.8）分］。 结论： 皮肤损害严重的PsA患者承受着更重的疾病负担，因此，临床医生应给予重度皮疹患者更多关注。除皮疹外，同时对患者的关节炎、指甲病变等临床表现着重询问并进行详细体检。." @default.
• W4283720170 created "2022-07-01" @default.
• W4283720170 creator A5018033448 @default.
• W4283720170 creator A5026867765 @default.
• W4283720170 creator A5033737213 @default.
• W4283720170 creator A5044864813 @default.
• W4283720170 creator A5053100047 @default.
• W4283720170 creator A5073603031 @default.
• W4283720170 creator A5083474996 @default.
• W4283720170 creator A5087495331 @default.
• W4283720170 date "2022-07-01" @default.
• W4283720170 modified "2023-10-18" @default.
• W4283720170 title "[Association of skin lesion severity with clinical features of psoriatic arthritis]." @default.
• W4283720170 doi "https://doi.org/10.3760/cma.j.cn112138-20220302-00152" @default.
• W4283720170 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35764561" @default.
• W4283720170 hasPublicationYear "2022" @default.
• W4283720170 type Work @default.
• W4283720170 citedByCount "0" @default.
• W4283720170 crossrefType "journal-article" @default.
• W4283720170 hasAuthorship W4283720170A5018033448 @default.
• W4283720170 hasAuthorship W4283720170A5026867765 @default.
• W4283720170 hasAuthorship W4283720170A5033737213 @default.
• W4283720170 hasAuthorship W4283720170A5044864813 @default.
• W4283720170 hasAuthorship W4283720170A5053100047 @default.
• W4283720170 hasAuthorship W4283720170A5073603031 @default.
• W4283720170 hasAuthorship W4283720170A5083474996 @default.
• W4283720170 hasAuthorship W4283720170A5087495331 @default.
• W4283720170 hasConcept C126322002 @default.
• W4283720170 hasConcept C16005928 @default.
• W4283720170 hasConcept C2776260265 @default.
• W4283720170 hasConcept C2777011040 @default.
• W4283720170 hasConcept C2777077863 @default.
• W4283720170 hasConcept C2777402515 @default.
• W4283720170 hasConcept C2778143017 @default.
• W4283720170 hasConcept C2780564577 @default.
• W4283720170 hasConcept C30036603 @default.
• W4283720170 hasConcept C71924100 @default.
• W4283720170 hasConcept C90924648 @default.
• W4283720170 hasConceptScore W4283720170C126322002 @default.
• W4283720170 hasConceptScore W4283720170C16005928 @default.
• W4283720170 hasConceptScore W4283720170C2776260265 @default.
• W4283720170 hasConceptScore W4283720170C2777011040 @default.
• W4283720170 hasConceptScore W4283720170C2777077863 @default.
• W4283720170 hasConceptScore W4283720170C2777402515 @default.
• W4283720170 hasConceptScore W4283720170C2778143017 @default.
• W4283720170 hasConceptScore W4283720170C2780564577 @default.
• W4283720170 hasConceptScore W4283720170C30036603 @default.
• W4283720170 hasConceptScore W4283720170C71924100 @default.
• W4283720170 hasConceptScore W4283720170C90924648 @default.
• W4283720170 hasIssue "7" @default.
• W4283720170 hasLocation W42837201701 @default.
• W4283720170 hasOpenAccess W4283720170 @default.
• W4283720170 hasPrimaryLocation W42837201701 @default.
• W4283720170 hasRelatedWork W10186008 @default.
• W4283720170 hasRelatedWork W1320415 @default.
• W4283720170 hasRelatedWork W13260057 @default.
• W4283720170 hasRelatedWork W15228753 @default.
• W4283720170 hasRelatedWork W17618961 @default.
• W4283720170 hasRelatedWork W1856643 @default.
• W4283720170 hasRelatedWork W20469016 @default.
• W4283720170 hasRelatedWork W209027 @default.
• W4283720170 hasRelatedWork W4041034 @default.
• W4283720170 hasRelatedWork W483946 @default.
• W4283720170 hasVolume "61" @default.
• W4283720170 isParatext "false" @default.
• W4283720170 isRetracted "false" @default.
• W4283720170 workType "article" @default.